Sabapathy, Suthakar, et al. “COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 23, no. 2, Nov. 2018, https://mail.jptcp.com/index.php/jptcp/article/view/206.